327 related articles for article (PubMed ID: 30483747)
1. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis.
Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y
Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.
Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L
J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842
[TBL] [Abstract][Full Text] [Related]
3. An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells.
Wang Q; Zhuang ZW; Cheng YM; Ma JQ; Xu SY; Zhong CL; Zhang KM
IUBMB Life; 2019 Jan; 71(1):93-104. PubMed ID: 30290058
[TBL] [Abstract][Full Text] [Related]
4. The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines.
Zhang Y; Jia LG; Wang P; Li J; Tian F; Chu ZP; Kang S
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2380-2390. PubMed ID: 30964163
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6.
Xin H; Liu N; Xu X; Zhang J; Li Y; Ma Y; Li G; Liang J
J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
Wu J; Sun Z; Sun H; Li Y
Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
[TBL] [Abstract][Full Text] [Related]
8. Effects of long non-coding RNA HOST2 on cell migration and invasion by regulating MicroRNA let-7b in breast cancer.
Lu PW; Li L; Wang F; Gu YT
J Cell Biochem; 2018 Jun; 119(6):4570-4580. PubMed ID: 29236319
[TBL] [Abstract][Full Text] [Related]
9. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
Sun E; Liu X; Lu C; Liu K
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b.
Gao Y; Meng H; Liu S; Hu J; Zhang Y; Jiao T; Liu Y; Ou J; Wang D; Yao L; Liu S; Hui N
Hum Mol Genet; 2015 Feb; 24(3):841-52. PubMed ID: 25292198
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
Yan J; Wang R; Wu Z
J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
[TBL] [Abstract][Full Text] [Related]
15. lncRNA Colorectal Neoplasia Differentially Expressed (CRNDE) Promotes Proliferation and Inhibits Apoptosis in Non-Small Cell Lung Cancer Cells by Regulating the miR-641/CDK6 Axis.
Fan YF; Yu ZP; Cui XY
Med Sci Monit; 2019 Apr; 25():2745-2755. PubMed ID: 30982057
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA DLEU1 inhibits the tumorigenesis of oral squamous cell carcinoma via regulation of miR‑149‑5p/CDK6 axis.
Lv T; Liu H; Wu Y; Huang W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880596
[TBL] [Abstract][Full Text] [Related]
17. Silence of FOXD2-AS1 inhibited the proliferation and invasion of esophagus cells by regulating miR-145-5p/CDK6 axis.
Shi W; Gao Z; Song J; Wang W
Histol Histopathol; 2020 Sep; 35(9):1013-1021. PubMed ID: 32524576
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
[TBL] [Abstract][Full Text] [Related]
19. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
[TBL] [Abstract][Full Text] [Related]
20. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]